Loading
ZP
Zomedica Pharmaceuticals Corp. Stock: price and insider trades · Canada
No insider purchase over the last 90 days. The latest, by POWERS JOHNNY D, was filed 07 Jul 2020.
Zomedica Pharmaceuticals Corp.: what insiders have been doing
This page follows insider dealings at Zomedica Pharmaceuticals Corp. as filed with SEDI. Zomedica Pharmaceuticals Corp. has had no insider filing for more than a year; the last one goes back to 20 August 2020.
Our records for Zomedica Pharmaceuticals Corp. go back to 2016, with 13 purchases and 23 sales on the open market in total.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Insider Decl.
103
Thresholds
n/a
Buy Volume
€290,643
13 ops. · all time
Sell Volume
€382,639
23 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 20 August 2020
Declarations103 total
Common SharesTSXSEDI:3591393
625,000 shares@ US$0.16100.0% of flowCommon Stock, without par valueSEC:0000905718-20-000734:0
Canonical exit: 5 Oct 2020 (T+90)
625,000 shares@ CA$0.16Common SharesTSXSEDI:3572959
Canonical exit: 29 Sept 2020 (T+90)
Common SharesTSXSEDI:3572943
Common SharesTSXSEDI:3566959
65,789 shares@ US$1.5212.0% of flowCommon Shares, without par valueSEC:0001171843-19-002177:0
65,789 shares@ CA$1.5211.1% of flowCommon SharesTSXSEDI:3347219
164,473 shares@ US$1.5229.8% of flowCommon Shares, without par valueSEC:0001171843-19-001790:0
164,473 shares@ CA$1.5227.8% of flowCommon SharesTSXSEDI:3337658
164,473 shares@ CA$1.5227.8% of flowCommon SharesTSXSEDI:3334964
164 shares@ US$1.890.0% of flowCommon Shares, without par valueSEC:0001171843-19-001649:0
164,473 shares@ US$1.5230.1% of flowCommon Shares, without par valueSEC:0001171843-19-001650:0
26,900 shares@ US$1.2047.8% of flowCommon Shares, without par valueSEC:0000905718-18-001001:0
100,000 shares@ CA$0.258.3% of flowCommon SharesTSXSEDI:3281696
175,000 shares@ CA$1.5091.7% of flowCommon SharesTSXSEDI:3281699
175,000 shares@ US$1.2091.9% of flowCommon Shares, without par valueSEC:0000905718-18-000960:0
200,000 shares@ US$1.2028.0% of flowCommon Shares, without par valueSEC:0000905718-18-000845:0
200,000 shares@ CA$1.50100.0% of flowCommon SharesTSXSEDI:3250760
200,000 shares@ US$2.1595.8% of flowCommon Shares, without par valueSEC:0000905718-18-000775:0
200,000 shares@ CA$2.1594.6% of flowCommon SharesTSXSEDI:3229201
10,000 shares@ CA$1.05Common SharesTSXSEDI:3221814
Canonical exit: 19 Jan 2017 (T+90)
10,000 shares@ CA$1.10Common SharesTSXSEDI:3221822
Canonical exit: 12 Feb 2017 (T+90)
19,000 shares@ CA$1.08Common SharesTSXSEDI:3221815
Canonical exit: 25 Jan 2017 (T+90)
8,800 shares@ CA$1.08Common SharesTSXSEDI:3221829
Canonical exit: 14 Feb 2017 (T+90)
25,000 shares@ CA$1.10Common SharesTSXSEDI:3221820
Canonical exit: 7 Feb 2017 (T+90)
25 of 103 declarations
About Zomedica Pharmaceuticals Corp.
Zomedica Pharmaceuticals Corp. is a company focused on developing health products for companion animals. It concentrates on diagnostic and therapeutic solutions to enhance animal health.
